CN104152409B - Method for simultaneous isolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells - Google Patents
Method for simultaneous isolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells Download PDFInfo
- Publication number
- CN104152409B CN104152409B CN201410405353.XA CN201410405353A CN104152409B CN 104152409 B CN104152409 B CN 104152409B CN 201410405353 A CN201410405353 A CN 201410405353A CN 104152409 B CN104152409 B CN 104152409B
- Authority
- CN
- China
- Prior art keywords
- cell
- culture
- dmem
- stem cells
- hscs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention relates to a canine stem cell isolated culture technology, and especially relates to a method for in vitro simultaneous insolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells. The method is characterized in that adherent culture of primary mesenchymal stem cells is carried out based on the separation of bone marrow mononuclear cells, half medium change is adopted, and a mononuclear cell culture suspension is added, that is, hematopoiesis microenvironment provided by the adherent-growth mesenchymal stem cells is used to culture the suspending-growth multifunctional hematopoietic stem cells, so the achieve the simultaneous isolated culture of the canine bone marrow mesenchymal stem cells and the multifunctional hematopoietic stem cells is realized.
Description
Technical field
The present invention relates to dog stem cell is separately cultured technology, especially the external dog medulla mesenchyma that is separately cultured simultaneously does thin
Born of the same parents and the technology of multi-functional candidate stem cell.
Background technology
Mesenchymal stem cells MSCs (Bone marrow mesenchymal stemcells, BMMSCs) is that one kind is deposited
It is the non-hematopoietic stem cell of marrow, convenient sources, without immunological rejection, the differentiation of tool polyphyly and high proliferative potentials exist in recent years
Field is repaired in basic research field, clinical tissue organ and disease treatment field presents extremely tempting prospect;It is multi-functional to make
Hemocytoblast (Hematopoietic stem cells, HSCs) is a blastoid cell in the hematopoietic tissues such as marrow, is had
Self directed differentiation (being divided into all kinds of mature blood cells) and go back to the nest that (i.e. Jing Peripheral Circulations enter after venoclysis
Enter medullary sinus, then across blood vessel endothelium barrier and be positioned at the extravascular space gap of marrow) etc. biological function, for blood cell
Regeneration and reconstruction play an important role.
Tradition separates the method for BMMSCs and HSCs mainly includes density-gradient centrifugation method, flow cytometric sorting method, magnetic
Pearl separating method etc., but action required complex steps are confined to, long, big to cellular damage, human factor is more for required time, and
The in vitro culture of HSCs needs to add various growth factors and inducible factor.Therefore need when carrying out mass cell and being separately cultured
The method for wanting a kind of time saving and energy saving and efficient cell separation culture.
The content of the invention
It is an object of the invention to set up one kind be separately cultured suitable for carrying out mass cell in vitro, can the efficiently same time-division
It is that the studies and clinical application of follow-up dog class stem cell provides material base and technology from the method for culture dog BMMSCs and HSCs
Support.
The invention discloses a kind of method for being separately cultured dog mesenchymal stem cells MSCs and multi-functional candidate stem cell, its
It is characterised by the basis of separating bone marrow single nuclear cell, while adhere-wall culture primary mescenchymal stem cell, measures using half
Liquid is changed, the method for adding mononuclearcell culture suspension, i.e., the hematopoiesis for being provided using the mescenchymal stem cell of adherent growth
The multi-functional candidate stem cell of microenvironment culture suspension growth, so as to reach and meanwhile be separately cultured dog mesenchymal stem cells MSCs and
The purpose of multi-functional candidate stem cell, concrete operation step is as follows:
The in-vitro separation of step 1, BMMSCs and HSCs:General anaesthesia experimental dog, posterior superior iliac spine preserved skin, sterilization, drape,
Divide 2~3 points of bone marrow extraction about 10ml altogether with the marrow puncture needle containing 1ml liquaemins, mixing is anti-condensation, and 50ml sterilizations are proceeded to rapidly
Centrifuge tube, is mixed with the dilution of equivalent DMEM/F12;The centrifuge tube that 10 bottoms add 5ml lymphocyte separation mediums is taken, addition
Lymphocyte separation medium concentration is 1.077 g/ml, and the adherent inflow equivalent marrow dilution of upper strata difference, sealing controls temperature 4
DEG C, centrifuge speed is 2000 r/min, and centrifugation 20min removes upper-layer fat cell, draws middle intersection tunica albuginea confluent monolayer cells,
Then washing interlayer cell is mixed with 4 DEG C of 10 ml DMEM/F12,20min, rotating speed 2000r/min, in removal is centrifuged again
Clear liquid, the above-mentioned washing interlayer cell step 1 time of repetition;With containing 15% FBS, 100 U/ml penicillin, 100 U/ml streptomysins
The resuspended deposits of DMEM/F12 culture medium 5ml;
Step 2, determination of trypan blue staining cell viability:0.4g trypan blues are taken, the 0.1 M PBS solutions of 100 ml are added
In, it is configured to 0.4% trypan blue solution, 0.1M PBS solutions formula:NaCl 8g, KCl 0.2g, Na2HPO4.12H2O
3.488g, KH2PO40.2g, plus three and boils off ionized water to 1000 ml, and adjustment pH value is that 7.4,0.22 m membrane filtrations are degerming.
Take the ml of 0.4% trypan blue solution, 0.5 ml, DMEM/F12 culture medium 0.3 and the ml of cell suspension 0.2 is fully mixed, use blood cell
Tally living cell counting (non-pigmented cells) and dead cell (pigmented cells), altogether 500 cells of number, calculate cell viability,
Cell viability (%)=(TCS-pigmented cells number)/TCS × 100%.As Trypan Blue cell viability >=
95%, then can carry out next step operation, otherwise repeat step 1(The in-vitro separation of repeat step 1, BMMSCs and HSCs);
The adherent BMMSCs of step 3, culture:With containing 15% FBS, 100 U/ml penicillin, 100 U/ml when cultivating first
The DMEM/F12 nutrient solutions adjustment cell density of streptomysin (dual anti-), with 1 × 106The nutrient solution inoculation of the ml of/ml cell densities 5
In 25 cm2Disposable Tissue Culture Flask in, be placed in 37 DEG C of temperature, 5% CO2, saturated humidity cell culture incubator in cultivate, training
Change liquid after supporting 3 days first, remove red blood cell, the marrow hemopoietic stem cells of suspension growth and other not adherent stem cells,
Changed liquid 1 time every 3 days later, that is, renew fresh containing 15% FBS, 100 U/ml penicillin, 100 U/ml streptomysins
DMEM/F12 nutrient solutions, when cell growth is to 70%~80% fusion, with 0.25% 2~3min of Trypsin Induced, with containing 10%
FBS and dual anti-DMEM/F12 terminate digestion, bottle wall cell is blown and beaten repeatedly, make single cell suspension by 1:3 pass on, and are inverted aobvious
Micro mirror is observed day by day, until attached cell is fusion together when being paved with bottom of bottle, repeats aforesaid operations, amplification is passed on repeatedly, collection;
The HSCs of step 4, culture suspension growth:Due to HSCs suspension growths in vitro, and need what stroma cell was supported
Growing environment, therefore during step 3 culture BMMSCs, when liquid is changed for the second time, discard the whole supernatants in cell bottle
Liquid, adds by the cell suspension obtained by step 1,2, close with cell is adjusted containing 10% FBS and dual anti-DMEM/F12 nutrient solutions
Spend for 1 × 106/ ml, draws 5 ml cell suspensions and is directly inoculated in above adherent layer, hereafter changes liquid per 6 days half amounts, i.e.,
2.5 ml suspension cultures are taken out from blake bottle, 20min, rotating speed 2000r/min is centrifuged, collected cell precipitation and be
HSCs, then add 2.5 ml containing 10% FBS and dual anti-DMEM/F12 nutrient solutions, continue culture by this method and go down,
Microscope observation of cell growing state is put, when adherent BMMSCs grows to 80% fusion, suspension growth can be simultaneously collected
The HSCs and BMMSCs of adherent growth;
Step 5, cellular identification:(1) Morphological Identification:The BMMSCs that adherent growth is observed under inverted microscope is in long shuttle
Shape or polygonal fibrocyte shape, the HSCs of suspension growth is rounded, and cell light, refractivity is good;(2) flow cytometry
Identification:The BMMSCs and HSCs of culture are taken respectively, and the single cell suspension that 300 l contain 2.5 × 106 is made with PBS;Dispense to
In the Eppendof pipes of 6 1.5ml, 50 l sheep blood serums closing 30min is separately added into;Be separately added into again the anti-CD14 in mouse source one,
CD34, CD44, CD11a, HLA2DR and each 5 l of control PBS, mix, and react 30min;PBS centrifuge washings 2 times, remove unmarked
On antibody;Each effective PBS is configured to 99 l cell suspensions;Often pipe adds 1 l FITC marks goat anti-mouse IgG (H+L)
Two resist, and mix, lucifuge reaction 15min at 37 DEG C;PBS centrifuge washings 2 times;Often pipe adds 1ml PBS and is suspended again cell, uses
The expression of flow cytomery cell surface antigen CD14, CD34, CD44, CD11a and HLA2DR;BMMSCs strongly expressed CD44
(mescenchymal stem cell specific molecular antigen), HSCs strongly expressed CD34 (candidate stem cell specific molecular antigen);
The frozen and recovery of step 6, BMMSCs and HSCs:(1) it is frozen:The every BMMSCs and HSCs in generation, except for continuing
Cultivate and carry out related experiment all outer, it is all frozen.Cells frozen storing liquid:10% DMSO, 40% FBS, 50% DMEM/F12 are tieed up
It is 1 × 10 to hold nutrient solution adjustment cell concentration6/ ml, in adding aseptic cell cryopreservation tube, the every ml of pipe 1.5, application program drop
Warm instrument is frozen in liquid nitrogen;(2) recover:It is rapid from liquid nitrogen to take out cell cryopreservation tube, 37 DEG C of water baths are put immediately into, gently
Shake makes it melt as early as possible, takes out cryopreservation tube, is opened with after 75% ethanol disinfection, suctions out cell suspension, injects centrifuge tube, rotating speed
2000r/min, is centrifuged 20min, removes supernatant, uses resuspended thin containing 10% FBS and dual anti-DMEM/F12 nutrient solution nutrient solutions
Born of the same parents are precipitated, and put 37 DEG C of temperature, 5% CO2, saturated humidity cell culture incubator in cultivate.
This method is innovated and improved in the method that tradition is separately cultured, and is overcome loaded down with trivial details when dog stem cell separates
Screening step, the multi-functional candidate stem cell of dog is suspended in nutrient solution, is difficult to grow, needs to add various growth factors and induction
The defect of the factor, can simultaneously be separately cultured dog mesenchymal stem cells MSCs and multi-functional Hematopoietic Stem is thin using the method for the present invention
Born of the same parents, resulting cellular morphology is homogeneous, shortens the time required to cultured cells, and two kinds of isolated stem cell purity are higher, increases
Grow very fast.The inventive method provides abundant material source for the research and application of dog class stem cell, with extensive dog class
Clinical medicine application prospect.
Specific embodiment
The in-vitro separation of embodiment 1, step 1, BMMSCs and HSCs:General anaesthesia experimental dog, posterior superior iliac spine preserved skin, disappears
Malicious, drape, with 2~3 points of common bone marrow extraction about 10ml of the marrow puncture needle containing 1ml liquaemins point, mixing is anti-condensation, proceeds to rapidly
50ml sterilization centrifuge tubes, are mixed with the dilution of equivalent DMEM/F12;Take 10 bottoms and add 5ml lymphocyte separation mediums (1.077
G/ml centrifuge tube), upper strata is carefully added into respectively (adherent inflow) equivalent marrow dilution, sealing.4 DEG C, 2000 r/min,
Centrifugation 20min removes upper-layer fat cell, careful to draw middle intersection tunica albuginea confluent monolayer cells.It is mixed with 4 DEG C of 10ml DMEM/F12
Even washing interlayer cell, 2000r/min is centrifuged 20min, removes supernatant, repeated washing 1 time;With containing 15% FBS, 100 U/
The resuspended deposits of DMEM/F12 culture medium 5ml of ml penicillin, 100 U/ml streptomysins;
Step 2, determination of trypan blue staining cell viability:Take 0.4 % trypan blues (PBS preparations) 0.5 ml, DMEM/F12 trainings
The ml of foster base 0.3 and the ml of cell suspension 0.2 are fully mixed, with blood counting chamber living cell counting (non-pigmented cells) and extremely
Cell (pigmented cells), altogether 500 cells of number, calculate cell viability, and cell viability (%)=(TCS-coloring is thin
Born of the same parents' number)/TCS × 100%.Such as Trypan Blue cell viability >=95%, then next step operation can be carried out, otherwise repeatedly be walked
Rapid 1;
The adherent BMMSCs of step 3, culture:With the DMEM/ containing 15% FBS and dual anti-(mycillin) when cultivating first
F12 culture mediums adjust cell density, with the culture that the nutrient solution of the ml of 1 × 106/ml cell densities 5 is inoculated in a diameter of 25 cm2
In bottle, 37 DEG C are put, cultivated in 5% CO2, the cell culture incubator of saturated humidity.Culture changes first liquid after 3 days, remove red blood cell,
The marrow hemopoietic stem cells of suspension growth and other not adherent stem cells.Changed liquid 1 time, cell growth every 3 days later
When 70%~80% fusion, 2~3min is digested with the ml of 0.25% trypsase+0.03%EDTA 3, with containing 10% FBS and double
Anti- DMEM/F12 terminates digestion, and bottle wall cell is blown and beaten repeatedly, makes single cell suspension by 1:3 pass on, and inverted microscope is day by day
Observation, until attached cell is fusion together when being paved with bottom of bottle, repeats aforesaid operations, amplification is passed on repeatedly, collection.
The HSCs of step 4, culture suspension growth:Due to HSCs suspension growths in vitro, and need what stroma cell was supported
Growing environment, therefore during step 3 culture BMMSCs, when liquid is changed for the second time, discard the whole supernatants in cell bottle
Liquid, adds by the cell suspension obtained by step 1,2.With the DMEM/F12 nutrient solutions containing 10% FBS and dual anti-(mycillin)
Adjustment cell density is 1 × 106/ ml, draws 5 ml cell suspensions and is directly inoculated in above adherent layer.Hereafter per 6 days
Half amount changes liquid, i.e., 2.5 ml suspension cultures are taken out from blake bottle, and 2000r/min is centrifuged 20min, collects cell precipitation
As HSCs.Then 2.5 ml fresh mediums are added, is continued culture by this method and is gone down, the growth of inverted microscope observation of cell
Situation, when adherent BMMSCs grows to 80% fusion, can simultaneously collect the HSCs of suspension growth and adherent growth
BMMSCs。
Step 5, cellular identification:(1) Morphological Identification:The BMMSCs that adherent growth is observed under inverted microscope is in spindle shape
Or polygonal fibrocyte shape, the HSCs of suspension growth is rounded, and cell light, refractivity is good.(2) flow cytometry mirror
It is fixed:The BMMSCs and HSCs of culture are taken respectively, 300 l are made with PBS and contains 2.5 × 106Individual single cell suspension;Dispense to 6
In the Eppendof pipes of 1.5ml, 50 l sheep blood serums closing 30min is separately added into;Be separately added into again the anti-CD14 in mouse source one,
CD34, CD44, CD11a, HLA2DR and each 5 l of control PBS, mix, and react 30min;PBS centrifuge washings 2 times, remove unmarked
On antibody.Each effective PBS is configured to 99 l cell suspensions;Often pipe adds 1 l FITC marks goat anti-mouse IgG (H+L)
Two resist, and mix, lucifuge reaction 15min at 37 DEG C;PBS centrifuge washings 2 times;Often pipe adds 1ml PBS and is suspended again cell, uses
The expression of flow cytomery cell surface antigen CD14, CD34, CD44, CD11a and HLA2DR.BMMSCs strongly expressed CD44
(mescenchymal stem cell specific molecular antigen), HSCs strongly expressed CD34 (candidate stem cell specific molecular antigen).
The frozen and recovery of step 6, BMMSCs and HSCs:(1) it is frozen:The every BMMSCs and HSCs in generation, except for continuing
Cultivate and carry out related experiment all outer, it is all frozen.Cells frozen storing liquid:10% DMSO, 40% FBS, 50% DMEM/F12 are tieed up
It is 1 × 10 to hold nutrient solution adjustment cell concentration6/ ml, in adding aseptic cell cryopreservation tube, the every ml of pipe 1.5, application program drop
Warm instrument is frozen in liquid nitrogen;(2) recover:It is rapid from liquid nitrogen to take out cell cryopreservation tube, 37 DEG C of water baths are put immediately into, gently
Shake makes it melt as early as possible, takes out cryopreservation tube, is opened with after 75% ethanol disinfection, suctions out cell suspension, injects centrifuge tube, rotating speed
2000r/min, is centrifuged 20min, removes supernatant, uses resuspended thin containing 10% FBS and dual anti-DMEM/F12 nutrient solution nutrient solutions
Born of the same parents are precipitated, and put 37 DEG C of temperature, 5% CO2, saturated humidity cell culture incubator in cultivate.
Claims (1)
1. a kind of method for being separately cultured dog mesenchymal stem cells MSCs and multi-functional candidate stem cell, it is characterised in that separating
On the basis of BMNC, while adhere-wall culture primary mescenchymal stem cell, liquid is changed using half amount, added single
The method of nucleus culture suspension, i.e., the hematopoieticmicroenviron-ment culture for being provided using the mescenchymal stem cell of adherent growth is suspended and is given birth to
Long multi-functional candidate stem cell, so as to reach while being separately cultured dog mesenchymal stem cells MSCs and multi-functional candidate stem cell
Purpose, concrete operation step is as follows:
The in-vitro separation of step 1, BMMSCs and HSCs:General anaesthesia experimental dog, posterior superior iliac spine preserved skin, sterilization, drape, with containing
The common bone marrow extraction about 10ml of 2~3 points of the marrow puncture needle of 1ml liquaemins point, mixing is anti-condensation, and 50ml sterilization centrifugations are proceeded to rapidly
Pipe, is mixed with the dilution of equivalent DMEM/F12;Take the centrifuge tube that 10 bottoms add 5ml lymphocyte separation mediums, the lymph of addition
Cell separation liquid concentration is 1.077 g/ml, and the adherent inflow equivalent marrow dilution of upper strata difference, sealing controls 4 DEG C of temperature, from
Scheming rotating speed is 2000 r/min, and centrifugation 20min removes upper-layer fat cell, draws middle intersection tunica albuginea confluent monolayer cells, then
Washing interlayer cell is mixed with 4 DEG C of 10 ml DMEM/F12,20min, rotating speed 2000r/min are centrifuged again, remove supernatant
Liquid, the above-mentioned washing interlayer cell step 1 time of repetition;With containing 15% FBS, 100 U/ml penicillin, 100 U/ml streptomysins
The resuspended deposits of DMEM/F12 culture medium 5ml;
Step 2, determination of trypan blue staining cell viability:0.4g trypan blues are taken, in adding the 0.1 M PBS solutions of 100 ml, is matched somebody with somebody
Make 0.4% trypan blue solution, 0.1M PBS solutions formula:NaCl 8g, KCl 0.2g, Na2HPO4.12H2O 3.488g,
KH2PO40.2g, plus three and boils off ionized water to 1000 ml, and adjustment pH value is that 7.4,0.22 m membrane filtrations are degerming;
Take the ml of 0.4% trypan blue solution, 0.5 ml, DMEM/F12 culture medium 0.3 and the ml of cell suspension 0.2 is fully mixed, not
Pigmented cells are living cells, and pigmented cells are dead cell, with blood counting chamber living cell counting and dead cell, number 500 altogether
Cell, calculates cell viability, cell viability (%)=(TCS-pigmented cells number)/TCS × 100%;Such as platform
Expect blue staining cell vigor >=95%, then can carry out next step operation, otherwise repeat step 1;
The adherent BMMSCs of step 3, culture:With containing 15% FBS, 100 U/ml penicillin, 100 U/ml chains when cultivating first
The DMEM/F12 nutrient solutions adjustment cell density of mycin, with 1 × 106The nutrient solution of the ml of/ml cell densities 5 is inoculated in 25 cm2's
In disposable Tissue Culture Flask, 37 DEG C of temperature, 5% CO are placed in2, saturated humidity cell culture incubator in cultivate, it is first after culture 3 days
It is secondary to change liquid, red blood cell, the marrow hemopoietic stem cells of suspension growth and other not adherent stem cells are removed, later every 3
It changes liquid 1 time, that is, renew the fresh cultures of the DMEM/F12 containing 15% FBS, 100 U/ml penicillin, 100 U/ml streptomysins
Liquid, when cell growth is to 70%~80% fusion, with 0.25% 2~3min of Trypsin Induced, with containing 10% FBS and dual anti-
DMEM/F12 terminates digestion, and bottle wall cell is blown and beaten repeatedly, makes single cell suspension by 1:3 pass on, and inverted microscope is observed day by day,
When being paved with bottom of bottle up to attached cell is fusion together, repeat aforesaid operations, amplification is passed on repeatedly, collect;
The HSCs of step 4, culture suspension growth:Due to HSCs suspension growths in vitro, and need the growth that stroma cell supports
Environment, therefore during step 3 culture BMMSCs, when liquid is changed for the second time, the whole supernatants in cell bottle are discarded, plus
Enter by the cell suspension obtained by step 1,2, be 1 with cell density is adjusted containing 10% FBS and dual anti-DMEM/F12 nutrient solutions
×106/ ml, draws 5 ml cell suspensions and is directly inoculated in above adherent layer, hereafter changes liquid per 6 days half amounts, i.e., from training
2.5 ml suspension cultures are taken out in foster bottle, 20min, rotating speed 2000r/min is centrifuged, collected cell precipitation and be HSCs, so
Add afterwards 2.5 ml containing 10% FBS and dual anti-DMEM/F12 nutrient solutions, continue culture by this method and go down, inverted microscope
Observation of cell growing state, when adherent BMMSCs grows to 80% fusion, can simultaneously collect the HSCs and note of suspension growth
The BMMSCs of wall growth;
Step 5, cellular identification:(1) Morphological Identification:The BMMSCs of adherent growth is observed under inverted microscope in spindle shape or
Polygonal fibrocyte shape, the HSCs of suspension growth is rounded, and cell light, refractivity is good;(2) flow cytometry identification:
The BMMSCs and HSCs of culture are taken respectively, and the single cell suspension that 300 l contain 2.5 × 106 is made with PBS;Dispense to 6
In the Eppendof pipes of 1.5ml, 50 l sheep blood serums closing 30min is separately added into;Be separately added into again the anti-CD14 in mouse source one, CD34,
CD44, CD11a, HLA2DR and each 5 l of control PBS, mix, and react 30min;PBS centrifuge washings 2 times, remove on unmarked
Antibody;Each effective PBS is configured to 99 l cell suspensions;Often pipe adds 1 l FITC marks goat anti-mouse IgG (H+L) two
It is anti-, mix, lucifuge reaction 15min at 37 DEG C;PBS centrifuge washings 2 times;Often pipe adds 1ml PBS and is suspended again cell, with stream
Formula cell instrument detects the expression of cell surface antigen CD14, CD34, CD44, CD11a and HLA2DR;BMMSCs strongly expressed CD44,
HSCs strongly expressed CD34;
The frozen and recovery of step 6, BMMSCs and HSCs:(1) it is frozen:The every BMMSCs and HSCs in generation, except for Continuous education
It is all outer with related experiment is carried out, it is all frozen;
Cells frozen storing liquid:It is 1 × 10 that 10% DMSO, 40% FBS, 50% DMEM/F12 maintain nutrient solution adjustment cell concentration6/ ml,
In adding aseptic cell cryopreservation tube, the every ml of pipe 1.5, application program cooling instrument is frozen in liquid nitrogen;(2) recover:From liquid nitrogen
In it is rapid take out cell cryopreservation tube, be put immediately into 37 DEG C of water baths, be shaken gently for making it melt as early as possible, take out cryopreservation tube, use 75%
Open after ethanol disinfection, suction out cell suspension, inject centrifuge tube, rotating speed 2000r/min is centrifuged 20min, removes supernatant, uses
Containing 10% FBS and dual anti-DMEM/F12 nutrient solution nutrient solutions re-suspended cell precipitation, 37 DEG C of temperature, 5% CO are put2, saturated humidity
Cell culture incubator in cultivate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410405353.XA CN104152409B (en) | 2014-08-18 | 2014-08-18 | Method for simultaneous isolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410405353.XA CN104152409B (en) | 2014-08-18 | 2014-08-18 | Method for simultaneous isolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104152409A CN104152409A (en) | 2014-11-19 |
CN104152409B true CN104152409B (en) | 2017-05-03 |
Family
ID=51878037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410405353.XA Active CN104152409B (en) | 2014-08-18 | 2014-08-18 | Method for simultaneous isolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104152409B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6153653B2 (en) * | 2015-12-07 | 2017-06-28 | 株式会社Cells Power | Stem cell culture method |
CN105394027A (en) * | 2016-01-18 | 2016-03-16 | 黄林海 | Method for cryopreserving mesenchymal stem cells with low cryo-damage |
CN106178108A (en) * | 2016-07-19 | 2016-12-07 | 安徽惠恩生物科技股份有限公司 | A kind of for repair in trauma rich in the preparation method of the degradable biological film of stem cell extract |
CN106491393B (en) * | 2016-12-13 | 2019-02-26 | 云南农业大学 | Dog stem cell factor shampoo and preparation method thereof |
CN106727704A (en) * | 2016-12-26 | 2017-05-31 | 云南农业大学 | Dog stem cell secretion factor injection |
CN109370986A (en) * | 2018-12-11 | 2019-02-22 | 南京农业大学 | The extracting method and its preparation of a kind of dog fat stem cell and application |
CN110669727A (en) * | 2019-11-07 | 2020-01-10 | 深圳科康干细胞技术有限公司 | Preparation method and application of mesenchymal stem cell membrane |
-
2014
- 2014-08-18 CN CN201410405353.XA patent/CN104152409B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104152409A (en) | 2014-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104152409B (en) | Method for simultaneous isolated culture of canine bone marrow mesenchymal stem cells and multifunctional hematopoietic stem cells | |
Abbott et al. | An improved in vitro blood–brain barrier model: rat brain endothelial cells co-cultured with astrocytes | |
RU2323252C1 (en) | Method for culturing human mesenchymal stem cells ex vivo | |
CN106434557B (en) | The method for preparing CD34 positive cell by umbilical cord mesenchymal stem cells | |
CN104726406B (en) | It is a kind of to induce the method that dental pulp Derived from Mesenchymal Stem Cells is nerve cell | |
CN106619722A (en) | Neural stem cell injection for treating brain damage disease | |
CN105132369B (en) | A kind of derivant and inducing culture that mescenchymal stem cell is converted into testosterone secretion cell | |
CN106801032A (en) | The construction method of people's amnioic epithelium stem cell bank | |
CN102154202A (en) | Method for storing endometrial stem cells | |
CN109893541B (en) | Application of exosome derived from menstrual blood stem cells in preparation of medicine for treating intrauterine adhesion | |
CN104357387A (en) | Method for separating human adipose-derived stem cells from human adipose tissues | |
CN107974429A (en) | A kind of method and Optimal Medium of quick separating culture human airway epithelial cells | |
KR20190112186A (en) | Method and system for regenerating hair using 3D organoid system of hair follicle stem cells | |
CN107921182A (en) | Mechanical device and method for isolation medium vasculature part | |
CN107663514A (en) | A kind of serum free medium of human umbilical cord mesenchymal stem cells | |
CN109385396A (en) | Clinical application grade umbilical cord mesenchymal stem cells and its method for separating and preparing | |
CN103215223B (en) | Method for constructing in vitro model of interaction of human intervertebral disc nucleus pulposus cell and immune cell | |
CN105062970B (en) | A kind of derivant and induction differentiation complete medium that mescenchymal stem cell is induced to neuroblast | |
CN107287156A (en) | A kind of isolated culture method of fat mesenchymal stem cell and its application | |
CN103320385B (en) | Humanized's differentiated hepatoma cell strain HL1017 and construction process thereof | |
CN103396985A (en) | Method for inducing differentiation of human umbilical cord mesenchymal stem cells into hepatocytes and applications | |
CN108715831A (en) | Application of the mescenchymal stem cell conditioned medium in the cellular damage for improving cardiomyocytes induced by hypoxia and reoxygenation | |
CN104630135A (en) | Method for large scale preparation of liver stem cells, and uses of liver stem cells | |
CN107022648A (en) | A kind of cellular resources store-service method | |
CN101407790B (en) | Processing method for enhancing human medulla ossium mesenchyma stem cell paracrine ability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |